Skip to main content

Table 2 Association of TFF1 and nephrolithiasis risk in each stage

From: Association of functional genetic variants in TFF1 and nephrolithiasis risk in a Chinese population

Stage

tagSNPs

Alleles (major/minor)

Casesa

Controlsa

Adjusted OR (95% CI)b

  

Co-dominant model

Additive model

Dominant model

Recessive model

Pc

Padjd

Ptrend

Hetb

Homb

Discovery

rs225355

G > A

147/72/11

151/93/6

0.74

(0.50–1.09)

2.00

(0.70–5.75)

0.81

(0.55–1.18)

0.81

(0.55–1.18)

2.23

(0.78–6.34)

0.268

1.000

0.185

rs2839488

C > G

129/79/19

147/86/16

1.01

(0.68–1.51)

1.50

(0.72–3.10)

1.12

(0.84–1.51)

1.08

(0.74–1.57)

1.49

(0.73–3.04)

0.433

1.000

0.594

rs13051704

C > G

140/63/10

131/107/12

0.53

(0.35–0.79)

0.70

(0.29–1.73)

0.64

(0.46–0.89)

0.54

(0.37–0.80)

0.90

(0.37–2.17)

0.008

0.056

< 0.001

rs225358

C > T

128/82/20

143/79/28

1.21

(0.81–1.81)

0.82

(0.43–1.56)

1.01

(0.76–1.32)

1.11

(0.77–1.61)

0.77

(0.41–1.43)

0.969

1.000

0.499

rs3761376

G > A

64/112/51

100/117/33

1.47

(0.97–2.23)

2.21

(1.28–3.85)

1.48

(1.14–1.94)

1.64

(1.10–2.43)

1.76

(1.08–2.88)

0.004

0.028

0.003

rs225359

G > A

121/90/19

144/84/22

1.36

(0.92–2.02)

1.05

(0.53–2.07)

1.15

(0.86–1.53)

1.30

(0.90–1.88)

0.93

(0.48–1.80)

0.335

1.000

0.451

rs35448902

C > T

151/65/11

140/97/13

0.63

(0.43–0.94)

0.72

(0.30–1.69)

0.72

(0.53–0.99)

0.64

(0.44–0.94)

0.84

(0.36–1.96)

0.043

0.301

0.028

Validation

rs3761376

G > A

108/123/66

186/214/61

0.97

(0.69–1.36)

1.83

(1.18–2.84)

1.28

(1.03–1.58)

1.16

(0.85–1.59)

1.86

(1.25–2.78)

0.026

< 0.001

Combined

rs3761376

G > A

172/235/117

286/331/94

1.15

(0.88–1.51)

2.01

(1.42–2.85)

1.37

(1.16–1.62)

1.35

(1.05–1.73)

1.86

(1.35–2.54)

< 0.001

< 0.001

  1. Bold font indicates P values < 0.05, which were statistically significant
  2. aMajor homozygote/heterozygote/rare homozygote between cases and controls
  3. bLogistic regression model with adjustment for age, sex, hypertension and smoking status in co-dominant (het: heterozygote vs. major homozygote; hom: rare homozygote vs. major homozygote), additive (rare homozygote vs. heterozygote vs. major homozygote), dominant (heterozygote/rare homozygote vs. major homozygote), recessive (rare homozygote vs. heterozygote / major homozygote) models; OR, odds ratio; CI, confidence interval
  4. cP for additive model
  5. dPadj adjusted by Bonferroni correction